会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 3. 发明申请
    • Biological bioadhesive compositions and methods of preparation and use
    • 生物生物粘附剂组合物及其制备和使用方法
    • US20080089880A1
    • 2008-04-17
    • US11799104
    • 2007-04-30
    • Sam AustinThomas Davis
    • Sam AustinThomas Davis
    • A61K38/48
    • A61K38/363A61K31/573A61K38/4833C12Y304/21005A61K2300/00
    • The present invention relates generally to the preparation and use of biological tissue adhesives which rely on combining fibrinogen and thrombin. More particularly, the present invention relates to a method of preparing a fibrin sealant whereby said sealant is formed by reconstituting the fibrinogen or the thrombin component in the presence of biological and/or non-biological agents such as drugs, chemicals, and proteins. Preferably, these agents are introduced in solution, such as for example, a corticosteroid-containing solution like a betamethasone solution containing betamethasone acetate or betamethasone sodium phosphate; a triamcinolone solution; or a methylprednisolone solution. These solutions may be substituted for, or provided as a complement to, other solutions that are typically used in the preparation of fibrin sealants such as, for example, calcium chloride. The invention further relates to a novel method of using the improved fibrin sealant whereby the sealant and accompanying agent(s) are delivered directly to a critical site within the body and sealed in place due to the bio-static quality of the sealant. This provides therapeutic value to patients through prolonged presence, and optionally time-released delivery, of the specific agent(s) at the critical site.
    • 本发明一般涉及依赖于组合纤维蛋白原和凝血酶的生物组织粘合剂的制备和应用。 更具体地说,本发明涉及一种制备纤维蛋白密封剂的方法,其中所述密封剂通过在生物和/或非生物制剂如药物,化学品和蛋白质的存在下重构纤维蛋白原或凝血酶组分来形成。 优选将这些试剂引入溶液中,例如含有皮质类固醇的溶液,如含有醋酸倍他米松或倍他米松磷酸钠的倍他米松溶液; 曲安奈德溶液; 或甲基强的松龙溶液。 这些溶液可以代替通常用于制备纤维蛋白密封剂例如氯化钙的其它溶液的补充,或作为其补充。 本发明还涉及使用改进的纤维蛋白密封剂的新方法,其中密封剂和伴随剂直接输送到体内的关键部位并由于密封剂的生物静态质量而被密封就位。 这通过在关键部位的特定药剂的长期存在和任选的时间释放的递送来为患者提供治疗价值。
    • 5. 发明申请
    • Biological bioadhesive compositions and methods of preparation and use
    • 生物生物粘附剂组合物及其制备和使用方法
    • US20050152961A1
    • 2005-07-14
    • US11003106
    • 2004-12-04
    • Sam AustinThomas Davis
    • Sam AustinThomas Davis
    • A61L24/00A61L24/10A61L27/22A61L31/04A61M37/00
    • A61L24/106A61L24/0015A61L27/225A61L31/046A61L2300/222A61L2300/418A61L2300/43A61L2300/45
    • The present invention relates generally to the preparation and use of biological tissue adhesives which rely on combining fibrinogen and thrombin. More particularly, the present invention relates to a method of preparing a fibrin sealant whereby said sealant is formed by reconstituting the fibrinogen or the thrombin component in the presence of biological and/or non-biological agents such as drugs, chemicals, and proteins. Preferably, these agents are introduced in solution, such as for example, a corticosteroid-containing solution like a betamethasone solution containing betamethasone acetate or betamethasone sodium phosphate; a triamicinolone solution; or a methylprednisolone solution. These solutions may be substituted for, or provided as a complement to, other solutions that are typically used in the preparation of fibrin sealants such as, for example, calcium chloride. The invention further relates to a novel method of using the improved fibrin sealant whereby the sealant and accompanying agent(s) are delivered directly to a critical site within the body and sealed in place due to the bio-static quality of the sealant. This provides therapeutic value to patients through prolonged presence, and optionally time-released delivery, of the specific agent(s) at the critical site.
    • 本发明一般涉及依赖于组合纤维蛋白原和凝血酶的生物组织粘合剂的制备和应用。 更具体地说,本发明涉及一种制备纤维蛋白密封剂的方法,其中所述密封剂通过在生物和/或非生物制剂如药物,化学品和蛋白质的存在下重构纤维蛋白原或凝血酶组分来形成。 优选将这些试剂引入溶液中,例如含有皮质类固醇的溶液,如含有醋酸倍他米松或倍他米松磷酸钠的倍他米松溶液; 曲马松醇溶液; 或甲基强的松龙溶液。 这些溶液可以代替通常用于制备纤维蛋白密封剂例如氯化钙的其它溶液的补充,或作为其补充。 本发明还涉及使用改进的纤维蛋白密封剂的新方法,其中密封剂和伴随剂直接输送到体内的关键部位并由于密封剂的生物静态质量而被密封就位。 这通过在关键部位的特定药剂的长期存在和任选的时间释放的递送来为患者提供治疗价值。
    • 7. 发明授权
    • Hydrogenation process of unsaturated hydrocarbons employing impregnated
alumina containing material
    • 使用含浸氧化铝的材料的不饱和烃的氢化过程
    • US4824556A
    • 1989-04-25
    • US212838
    • 1988-06-29
    • Karlheinz K. BrandesSimon G. KukesThomas Davis
    • Karlheinz K. BrandesSimon G. KukesThomas Davis
    • B01J37/20C10G45/04C10G45/00
    • B01J37/20C10G45/04
    • A composition of matter is prepared by a process comprising the steps of impregnating a alumina-containing support material with a thiosulfate (preferably ammonium thiosulfate), drying the thus impregnated material, impregnating the dried material with a transition metal compound, drying and calcining the transition metal impregnated material. This composition of matter is used as catalyst composition for hydrogenating unsaturated hydrocarbon compounds, and as catalyst composition for hydrotreating hydrocarbon-containing feed streams (in particular heavy oils) which contain metal and sulfur compounds as impurities.In another embodiment, a hydrotreating process comprises contacting hydrocarbon-containing feed stream (in particular heavy oils), which contains compounds of sulfur and metals, in the presence of a fixed catalyst bed comprising (X) at least one layer of impregnated substantially spherical alumina-containing particles, which have been prepared by a process comprising the steps of impregnating a specific starting material with (NH.sub.4).sub.2 S.sub.2 O.sub.3 and then heating the thus impregnated material at about 500.degree.-900.degree. C. for improved crush strength retention. In a preferred embodiment, the fixed catalyst bed further comprises at least one layer (Y) of catalyst particles comprising a refractory inorganic carrier and at least one hydrogenation promoter. A composition of matter comprising the impregnated, spherical alumina-containing particles described above, and a process for preparing them are also provided.
    • 通过包括以下步骤的方法制备物质组合物,所述方法包括用硫代硫酸盐(优选硫代硫酸铵)浸渍含氧化铝的载体材料,干燥如此浸渍的材料,用过渡金属化合物浸渍干燥的材料,干燥和煅烧过渡 金属浸渍材料。 该物质组合物用作用于氢化不饱和烃化合物的催化剂组合物,以及用作加氢处理含有金属和硫化合物作为杂质的含烃进料流(特别是重油)的催化剂组合物。 在另一个实施方案中,加氢处理方法包括在固定的催化剂床存在下使包含硫和金属化合物的含烃进料流(特别是重油)与含有(X)至少一层浸渍的基本上为球形的氧化铝 其通过包括以下步骤制备的方法制备,所述方法包括用(NH 4)2 S 2 O 3浸渍特定原料,然后在约500-900℃加热如此浸渍的材料,以改善压碎强度保持性。 在优选的实施方案中,固定催化剂床还包含至少一层包含耐火无机载体和至少一种氢化促进剂的催化剂颗粒层(Y)。 还提供了包含上述浸渍的含球形氧化铝颗粒的物质组合物及其制备方法。
    • 10. 发明申请
    • Ceiling newsletter system and method
    • 天花板通讯系统和方法
    • US20070249891A1
    • 2007-10-25
    • US11409160
    • 2006-04-21
    • Thomas Davis
    • Thomas Davis
    • A61M21/00
    • A61M21/0094A61M2021/005
    • A method for easing stress on a patient in a stressful treatment area, including the steps of: (a) providing at least one page of a periodically issued ceiling newsletter; (b) mounting at least two members of an attachment mechanism on a ceiling of the treatment area; (c) mounting at least two corresponding members of the attachment mechanism on a back side of each ceiling newsletter page; and (d) removably mounting the ceiling newsletter on the treatment area ceiling. Also included herein is a method including the steps of: a) subscribing to a ceiling newsletter; b) transcribing subscriber information to a customer list; c) mailing the ceiling newsletter issues to the subscribers periodically; and d) receiving the issue, affixing corresponding attachment mechanism members to the ceiling and to the back of each page of the ceiling newsletter, and removably attaching the ceiling newsletter to the treatment area ceiling.
    • 一种在紧张的治疗区域缓解患者压力的方法,包括以下步骤:(a)提供至少一页定期发布的天花板通讯; (b)将至少两个附接机构的构件安装在处理区域的天花板上; (c)将安装机构的至少两个对应的部件安装在每个天花板通讯页的背面; 及(d)将上限通讯录可拆卸地安装在处理区上限。 本文还包括一种方法,包括以下步骤:a)订阅上限通讯; b)将用户信息转录给客户列表; c)定期向用户发送上传通讯问题; 和d)收到这个问题,将相应的附属机构成员贴在天花板上的每一页的天花板和背面,并将天花板通讯可拆卸地附着在处理区上限。